Patent details
EP3960740 Title: CRYSTALLINE FORMS OF ETHYL ((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUORO-2,5-DIHYDROFURAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)-L-ALANINATE (GS-9131) VANILLATE FOR TREATING VIRAL INFECTIONS
Basic Information
- Publication number:
- EP3960740
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP211866439
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORMS OF ETHYL ((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUORO-2,5-DIHYDROFURAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)-L-ALANINATE (GS-9131) VANILLATE FOR TREATING VIRAL INFECTIONS
- French Title of Invention:
- FORMES CRYSTALLINES DE VANILLATE DE ((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUORO-2,5-DIHYDROFURAN-2-YL)OXY)MÉTHYL)(PHÉNOXY)PHOSPHORYL)-L-ALANINATE ÉTHYILIQUE (GS-9131) POUR LE TRAITEMENT D'INFECTIONS VIRALES
- German Title of Invention:
- KRISTALLINE FORMEN VON ETHYL((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUOR-2,5-DIHYDROFURAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)-L-ALANINAT (GS-9131) VANILLATE ZUR BEHANDLUNG VON VIRUSINFEKTIONEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 04/12/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 11/12/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 15/11/2023
- Unitary Effect Registration Date:
- 11/12/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 30/07/2018
- Grant date:
- 15/11/2023
- EP Publication Date:
- 02/03/2022
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/11/2023
- EP B1 Publication Date:
- 15/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/07/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/11/2023
- Name:
- Gilead Sciences, Inc.
- Address:
- 333 Lakeside Drive, Foster City, CA 94404, United States (US)
Inventor
1
- Name:
- WANG, Silas
- Address:
- United States (US)
2
- Name:
- SHI, Bing
- Address:
- United States (US)
3
- Name:
- LAPINA, Olga Viktorovna
- Address:
- United States (US)
Priority
- Priority Number:
- 201762539822 P
- Priority Date:
- 01/08/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07D 417/12; C07D 473/34; C07D 493/04; C07D 498/14; C07H 19/16; C07H 19/20; A61K 31/5365; A61K 31/5377; A61K 31/635; A61K 31/675; A61P 31/18;
Publication
European Patent Bulletin
1
- Issue number:
- 202346
- Publication date:
- 15/11/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202402
- Publication date:
- 10/01/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202402
- Publication date:
- 10/01/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|